SCIENTIFIC AND PRODUCTION COMPANY "DIAPROF-MED" informs

On September 18, 2020, the company launched and operated a medical device for in vitro diagnostics - DIA®-SARS-CoV-2-Ag Enzyme-linked immunosorbent assay for the detection of coronavirus antigen SARS-CoV-2.


The test system is designed to detect SARS-CoV-2 coronavirus antigen in human serum and plasma samples by enzyme-linked immunosorbent assay using standard open-type ELISA equipment.


In coordination with the President of DiaPrep Systems Inc. of the USA, Favorov MO post-marketing research begins in 8 countries.


ДЕКЛАРАЦІЯ ПРО ВІДПОВІДНІСТЬ DoC-Т1-26Ag
.
Download • 1.05MB

2 views0 comments